澳大利亚药剂师在社区药房实施慢性病查服务方面的经验和观点:定性研究
Ayana Korsa1,2, Ines Krass1, Connie Van1
1Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, Australia.
Exploratory research in clinical and social pharmacy
|September 8, 2025
概括
社区药剂师发现药房主导的慢性病 (CKD) 查试验在很大程度上是积极的. 关键的促进者包括资源和患者接受,而人员和专业间的沟通对可持续的CKD护理构成了挑战.
科学领域:
- 药房实践 在药房实践.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
背景情况:
- 药剂师在慢性病 (CKD) 管理中的作用越来越大,需要评估新的护理模式.
- 药房主导的查和药品在CKD (QUM-CKD) 试验中的质量使用旨在识别未被诊断的CKD并提高药物安全性.
- 这项研究侧重于药剂师在QUM-CKD试验中的实施经验.
研究的目的:
- 探索澳大利亚社区药剂师对实施QUM-CKD试验的看法.
- 确定在试验推出过程中遇到的促进者和障碍.
- 为提高药店主导的CKD服务的可持续性和有效性收集见解.
主要方法:
- 使用了一种描述性的现象学定性方法.
- 与13名社区药剂师进行了深入的,半结构化的电话采访.
- 对面试成绩单进行了综合演和归纳方法的专题分析.
主要成果:
- 药剂师普遍报告了QUM-CKD试验实施的积极经验.
- 促进者包括药剂师的知识,可用的资源,培训,感知到的好处,临床检测,团队方法和患者接受.
- 障碍包括人员短缺,时间限制,工作量,软件问题,患者不感兴趣以及与全科医生的专业间沟通挑战.
结论:
- 澳大利亚社区药剂师与QUM-CKD试验的经验主要是积极的.
- 关于成功和可持续实施的建议包括足够的员工,公平的报酬,利益相关者推广和强有力的专业间合作.
- 纳入药剂师的建议对于服务提升和长期可行性至关重要.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
346
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
01:25Chronic Kidney Disease I: Introduction
573
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
573
01:18Chronic Kidney Disease IV: Nursing Management
322
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
322
01:17Factors Affecting Renal Clearance: Renal Impairment
428
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
428
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214